Physician profile
David M Greer
NPI 1003807215
$3,187.73
in general payments reported to CMS, 2019-2025
9 companies · $626 in 2025
The $626 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,986 · 2022: $119 · 2023: $241 · 2024: $217 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,084.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,083.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medivance, INC. | $1,132.40 | 2019 | |
| Ucb, INC. | $862.27 | 2022-2025 | Briviact, Fintepla |
| C. R. Bard, INC. & Subsidiaries | $728.40 | 2019 | |
| Chiesi USA, INC. | $109.75 | 2025 | Cleviprex |
| Tg Therapeutics, INC. | $106.10 | 2025 | |
| Becton, Dickinson and Company | $104.58 | 2019 | |
| Acadia Pharmaceuticals INC | $100.29 | 2025 | Nuplazid |
| Jazz Pharmaceuticals INC. | $23.79 | 2023 | |
| Bard Access Systems, INC. | $20.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Greer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.